Recruiting NA Maxillary Sinus Floor Augmentation

Compares treatment options for Maxillary Sinus Floor Augmentation

Official title Osseodensification Versus Osteotome Internal Sinus Lifting in Delayed Implant Placement

ClinicalTrials.gov ID: NCT05495490

What this study is testing

What it's testing
The sinus lift technique through alveolar crest Osseodensification is conservative, minimally invasive, and minimally traumatic, utilizing hydropneumatic counterclockwise rotating instruments to lift the maxillary sinus floor without touching the Schneiderian membrane, thereby minimizing the risk of perforation. In contrast, the internal sinus lift technique utilizing osteotomes to raise the Schneiderian membrane eliminated hammering, making the technique more patient-friendly, with the placement of a graft biomaterial around the implant.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 40. Healthy volunteers may be eligible.

You may be able to join if

  • 1\. Patient partially edentulous with maxillary posterior edentulous ridge after extraction of more than 4 months.
  • 2\. Both sexes will be selected males and females.
  • 3\. Adult patients aged between 18 and 40 years of age.
  • 4\. Good general health (American Society of Anesthesiology Physical Status Ⅰ-Ⅱ).
  • 5\. Initial residual alveolar ridge height ranging between 4 to 6 mm according to preoperative CBCT.

You likely can't join if

  • 1\. Smokers.
  • 2\. Pregnant or lactating females.
  • 3\. Psychiatric disorders.
  • 4\. Uncontrolled systemic disease.
  • 5\. Hematologic diseases and coagulation disorders.
  • 6\. Chemotherapy or radiotherapy of the head and neck area, and immunocompromised status.
See the full eligibility criteria
Who can join
  • 1\. Patient partially edentulous with maxillary posterior edentulous ridge after extraction of more than 4 months.
  • 2\. Both sexes will be selected males and females.
  • 3\. Adult patients aged between 18 and 40 years of age.
  • 4\. Good general health (American Society of Anesthesiology Physical Status Ⅰ-Ⅱ).
  • 5\. Initial residual alveolar ridge height ranging between 4 to 6 mm according to preoperative CBCT.
  • 6\. No previous surgery or radiation treatment on the maxillary sinus.
What rules you out
  • 1\. Smokers.
  • 2\. Pregnant or lactating females.
  • 3\. Psychiatric disorders.
  • 4\. Uncontrolled systemic disease.
  • 5\. Hematologic diseases and coagulation disorders.
  • 6\. Chemotherapy or radiotherapy of the head and neck area, and immunocompromised status.
  • 7\. Medical conditions affecting bone metabolism and ongoing treatment with bisphosphonates drugs or systemic steroids.
  • 8\. Presence of acute or chronic sinus pathoses or sinus membrane perforation.

The study team makes the final eligibility decision.

Where it's taking place

  • Asyut, Egypt
  • Cairo, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 40 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Asyut, Egypt; Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.